Regeneron Pharmaceuticals
REGN
#288
Rank
โ‚ฌ65.39 B
Marketcap
617,00ย โ‚ฌ
Share price
-0.61%
Change (1 day)
-14.58%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚ฌ4.54 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ14.24 Billion. In 2024 the company made an earning of โ‚ฌ4.10 Billion, an increase over its 2023 earnings that were of โ‚ฌ3.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ4.54 B10.78%
2024 โ‚ฌ4.10 B13.83%
2023 โ‚ฌ3.60 B-13.57%
2022 โ‚ฌ4.17 B-47.9%
2021 โ‚ฌ8.00 B144.75%
2020 โ‚ฌ3.27 B56.86%
2019 โ‚ฌ2.08 B-4.87%
2018 โ‚ฌ2.19 B22.86%
2017 โ‚ฌ1.78 B56.3%
2016 โ‚ฌ1.14 B8.55%
2015 โ‚ฌ1.05 B54.53%
2014 โ‚ฌ0.68 B11.14%
2013 โ‚ฌ0.61 B72.13%
2012 โ‚ฌ0.35 B-285.93%
2011 -โ‚ฌ0.2 Billion121.73%
2010 -โ‚ฌ86.35 Million37.18%
2009 -โ‚ฌ62.95 Million-14.6%
2008 -โ‚ฌ73.71 Million-25.02%
2007 -โ‚ฌ98.31 Million6.32%
2006 -โ‚ฌ92.47 Million-186.52%
2005 โ‚ฌ0.10 B2103.7%
2004 โ‚ฌ4.84 M-105.66%
2003 -โ‚ฌ85.7 Million-18.18%
2002 -โ‚ฌ0.11 Billion42.33%
2001 -โ‚ฌ73.6 Million129.35%
2000 -โ‚ฌ32.09 Million51.87%
1999 -โ‚ฌ21.13 Million92.19%
1998 -โ‚ฌ11 Million66.23%
1997 -โ‚ฌ6.62 Million-55.49%
1996 -โ‚ฌ14.86 Million103.53%
1995 -โ‚ฌ7.31 Million-70.89%
1994 -โ‚ฌ25.08 Million-26.08%
1993 -โ‚ฌ33.93 Million114.67%
1992 -โ‚ฌ15.81 Million196.77%
1991 -โ‚ฌ5.33 Million87.88%
1990 -โ‚ฌ2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.08 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.63 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.10 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ7.81 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France